You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pancreatic Neuroendocrine Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • (no location specified)
Aug 4, 2023

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023

Development of New Personalised 3D Preclinical Models of

Recruiting
  • Pancreatic Neuroendocrine Tumor
    • Milan, MI, Italy
      IRCCS San Raffele Institute
    Nov 2, 2023

    Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

    Completed
    • Pancreatic Neuroendocrine Tumor G2
    • Octreotide LAR
    • (no location specified)
    Oct 17, 2023

    Multi-dimensional Fragmentomic Assay for Early Detection of

    Not yet recruiting
    • Pancreatic Neuroendocrine Tumor
    • Fragmentomic profiles of plasma cfDNA
    • (no location specified)
    Apr 27, 2023

    Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor, Endoscopic Ultrasound Trial in Nanning

    Recruiting
    • Nonfunctional Pancreatic Neuroendocrine Tumor
    • +2 more
    • EUS-guided ethanol ablation
    • EUS-guided lauromacrogol ablation
    • Nanning, Guangxi, China
      First Affiliated Hospital of Guangxi Medical University
    Sep 30, 2022

    Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

    Not yet recruiting
    • Metastatic Pancreatic Neuroendocrine Tumor
    • +4 more
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Jan 14, 2023

    Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic

    Recruiting
    • Hepatocarcinoma
    • Pancreatic Tumor
    • Hepatocellular carcinoma
    • +2 more
    • Clichy, France
      Hôpital Beaujon
    Mar 20, 2023

    Pancreatic Tumor, Benign, Pancreatic Neuroendocrine Tumor, Solid Pseudopapillary Tumor of the Pancreas Trial in Shanghai (MPD

    Not yet recruiting
    • Pancreatic Tumor, Benign
    • +2 more
    • MPD Repair or Reconstruction
    • Shanghai, Shanghai, China
      Department of Pancreatic Surgery, Fudan University Shanghai Canc
    Aug 29, 2023

    Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

    Not yet recruiting
    • Adrenal Cortical Carcinoma
    • +3 more
    • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
    • Shanghai, Shanghai, China
      Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
    Nov 19, 2023

    Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)

    Active, not recruiting
    • Carcinoid Tumor
    • Pancreatic Neuroendocrine Tumor
    • Boston, Massachusetts
    • +1 more
    Jul 15, 2022

    Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Newport Beach, California
    • +2 more
    Aug 16, 2023

    Through Detection of Elastase-1 Combined With Other Examinations

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +5 more
    • Pancreatic elastase-1 in blood serum
    • Jinan, Shandong, China
      Ning Zhong
    Sep 10, 2023

    Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in

    Not yet recruiting
    • Pancreatic Neuroendocrine Tumor
    • Pancreas Cancer
    • cytoreductive surgery
    • +2 more
    • Chicago, Illinois
      The University of Chicago
    Nov 8, 2022

    Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)

    Recruiting
    • Multiple Endocrine Neoplasia Type 1
    • Pancreatic Neuroendocrine Tumor
    • EUS-guided fine-needle injection
    • Nanning, Guangxi, China
      First Affiliated Hospital of Guangxi Medical University
    Sep 24, 2022

    Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

    Recruiting
    • Pancreatic Neuroendocrine Tumor
    • peptide receptor radionuclide therapy with Y-90-DOTATOC
    • Milano, Italy
    • +1 more
    Sep 30, 2022

    Metastatic Malignant Tumor in the Liver, Pancreatic Neuroendocrine Tumor, Stage I Pancreatic Neuroendocrine Tumor AJCC v8 Trial

    Recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • +4 more
    • Ames, Iowa
    • +5 more
    Dec 3, 2021

    Gastrointestinal Stromal Tumors, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumor Trial in Changchun (Sunitinib malate

    Completed
    • Gastrointestinal Stromal Tumors
    • +2 more
    • Sunitinib malate capsules generic product
    • Sunitinib malate capsules reference product
    • Changchun, Jilin, China
      Affiliated Hospital of Changchun University of Traditional Chine
    Apr 6, 2023

    Artificial Intelligence in EUS for Diagnosing Pancreatic Solid

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +3 more
    • EUS-AI model
    • (no location specified)
    Jul 25, 2022

    Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,

    Not yet recruiting
    • Metastatic Pancreatic Neuroendocrine Tumor
    • Unresectable Pancreatic Neuroendocrine Carcinoma
    • Lutetium Lu 177 Dotatate
    • +4 more
    • (no location specified)
    Feb 10, 2022

    Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

    Not yet recruiting
    • Advanced Gastroenteropancreatic Neuroendocrine Tumor
    • (no location specified)
    Oct 16, 2023

    Pancreatic Tumor, Benign, Pancreatic Tumors, Pancreatic Adenocarcinoma Trial in Houston (Distal Pancreatectomy Sealing Using

    Completed
    • Pancreatic Tumor, Benign
    • +13 more
    • Distal Pancreatectomy Sealing Using LTW
    • Houston, Texas
      Baylor CHI St. Luke's Medical Center
    Apr 4, 2022

    Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma, Pancreatic Carcinoma Trial in Tianjin (Surufatinib, Sintilimab)

    Recruiting
    • Neuroendocrine Tumor Grade 3
    • +2 more
    • Tianjin, Tianjin, China
      Rui Liu
    Nov 17, 2022

    Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

    Not yet recruiting
    • Advanced Gastroenteropancreatic Neuroendocrine Tumor
    • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
    • long-acting Octreotide.
    • (no location specified)
    May 22, 2023

    Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

    Recruiting
    • Neuroendocrine Tumors
    • +4 more
    • [212Pb] VMT-α-NET
    • [203Pb] VMT-α-NET SPECT/CT
    • Iowa City, Iowa
      Holden Comprehensive Cancer Center at the University of Iowa
    Nov 30, 2023